These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 7812957)
1. Cholecystokinin-B/gastrin receptor: a novel molecular probe for human small cell lung cancer. Matsumori Y; Katakami N; Ito M; Taniguchi T; Iwata N; Takaishi T; Chihara K; Matsui T Cancer Res; 1995 Jan; 55(2):276-9. PubMed ID: 7812957 [TBL] [Abstract][Full Text] [Related]
2. [Cholecystokinin-B/gastrin receptor is a novel molecular probe for human small cell lung cancer]. Matsumori Y; Katakami N; Iwata N; Matsui T Nihon Rinsho; 1996 Feb; 54(2):507-12. PubMed ID: 8838106 [TBL] [Abstract][Full Text] [Related]
3. NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis. van de Velde HJ; Senden NH; Roskams TA; Broers JL; Ramaekers FC; Roebroek AJ; Van de Ven WJ Cancer Res; 1994 Sep; 54(17):4769-76. PubMed ID: 8062278 [TBL] [Abstract][Full Text] [Related]
4. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth. Sethi T; Herget T; Wu SV; Walsh JH; Rozengurt E Cancer Res; 1993 Nov; 53(21):5208-13. PubMed ID: 8221657 [TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential. Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353 [TBL] [Abstract][Full Text] [Related]
6. Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation. Uchiyama B; Saijo Y; Kumano N; Abe T; Fujimura S; Ohkuda K; Handa M; Satoh K; Nukiwa T Clin Cancer Res; 1997 Oct; 3(10):1873-7. PubMed ID: 9815576 [TBL] [Abstract][Full Text] [Related]
7. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas. Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220 [TBL] [Abstract][Full Text] [Related]
8. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays. Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482 [TBL] [Abstract][Full Text] [Related]
9. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene. Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218 [TBL] [Abstract][Full Text] [Related]
10. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021 [TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors. Reubi JC; Schaer JC; Waser B Cancer Res; 1997 Apr; 57(7):1377-86. PubMed ID: 9102227 [TBL] [Abstract][Full Text] [Related]
13. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer. Grote HJ; Schmiemann V; Geddert H; Bocking A; Kappes R; Gabbert HE; Sarbia M Cancer; 2006 Apr; 108(2):129-34. PubMed ID: 16444703 [TBL] [Abstract][Full Text] [Related]
14. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment. Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405 [TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of the human delta opioid receptor in lung cancer. Schreiber G; Campa MJ; Prabhakar S; O'Briant K; Bepler G; Patz EF Anticancer Res; 1998; 18(3A):1787-92. PubMed ID: 9673405 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer. Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951 [TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies. Béhé M; Behr TM Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727 [TBL] [Abstract][Full Text] [Related]
18. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. Oue N; Mitani Y; Aung PP; Sakakura C; Takeshima Y; Kaneko M; Noguchi T; Nakayama H; Yasui W J Pathol; 2005 Oct; 207(2):185-98. PubMed ID: 16086444 [TBL] [Abstract][Full Text] [Related]
19. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer. Uchida K; Kojima A; Morokawa N; Tanabe O; Anzai C; Kawakami M; Eto Y; Yoshimura K J Cancer Res Clin Oncol; 2002 Dec; 128(12):633-40. PubMed ID: 12474049 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer. Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]